BioModels
Resource Center

IT vs SC Osmotic Pump Bleomycin-Induced Fibrosis Models

Are you interested in treating pulmonary fibrosis, but uncertain which preclinical model is the best fit? Fortunately, BioModels is here to help. We have experience with a variety of pulmonary fibrosis induction paradigms, including:

Today, we’re excited to share comparative data on our intratracheal bleomycin-induced and SC osmotic pump bleomycin-induced models.  If you have any questions about these models, the data, or would like to explore which induction paradigm best fits your study goals, please don’t hesitate to reach out!

Additionally, as the year comes to a close, we welcome the opportunity to discuss any year-end preclinical projects or your 2025 project budgets. Feel free to contact us at info@biomodels.com

*All disease modeling and lung function data collection was performed at BioModels, and the histopathology was performed by DTR Labs.

 

 

IT vs SC Osmotic Pump Bleomycin Induced Fibrosis Models

Back to All News

Daniel Lichtman

Managing Partner